Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Cogstate Ltd ( (AU:CGS) ) has issued an announcement.
Cogstate Ltd has announced an update on its ongoing share buy-back program, revealing that a total of 5,204,556 securities have been bought back prior to the previous day, with an additional 27,844 securities acquired on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, focusing on cognitive science and technology. The company provides digital brain health assessments and services, primarily targeting clinical trials and healthcare sectors.
YTD Price Performance: 25.00%
Average Trading Volume: 10,930
Technical Sentiment Signal: Sell
Current Market Cap: $147.8M
For an in-depth examination of CGS stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue